Document is current

Any future updates will be listed below

A phase II trial of small-dose bortezomib, lenalidomide and dexamethasone (sVRD) as consolidation/maintenance therapy in patients with multiple myeloma

Crossref DOI link: https://doi.org/10.1007/s00280-016-3163-y

Published Online: 2016-10-13

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark